AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Xvivo Perfusion AB (publ)

$6.88 +$0.34 (+5.20%)
OTC · 02 Sep 2026 20:00 UTC
Previous Close
$7.4
Day Range
$6.88 - $6.88
Year Range
$4.25$8.18
Market Cap
866.87M
AVG Volume
553
Trailing/Forward PE
90.68/-
PEG ratio
1.23
Dividend Yield
-
Next Earnings Date
2026-10-22
Primary Exchange
Other OTCUS
Revenue (SEK)
0250M500M750M1B2016201720182019202020212022202320242025
XVIPY Revenue (SEK) by year
PeriodRevenue (SEK)
2025804.87M
2024822.41M
2023597.54M
2022415.29M
2021258.39M
2020179.86M
2019220.84M
2018187.87M
2017148.34M
2016138.18M
Net Income (SEK)
-100M0100M200M2016201720182019202020212022202320242025
XVIPY Net Income (SEK) by year
PeriodNet Income (SEK)
202524.47M
2024172.18M
202391.82M
202218.43M
20218.15M
2020-43.73M
20194.94M
201812.69M
20176.26M
20161.5M
Operating Income (SEK)
-50M050M100M2016201720182019202020212022202320242025
XVIPY Operating Income (SEK) by year
PeriodOperating Income (SEK)
202588.08M
202488.35M
2023-4.85M
2022-9.21M
2021-18.5M
2020-45.67M
20193.94M
201814M
20177.11M
20162.73M
EBITDA (SEK)
-50M050M100M150M200M2016201720182019202020212022202320242025
XVIPY EBITDA (SEK) by year
PeriodEBITDA (SEK)
2025144.94M
2024129.72M
2023155.02M
202265.09M
202127.1M
2020-38.46M
201924.93M
201826.17M
201719.19M
20169.63M
Cash Flows (SEK)
-100M-50M050M100M2016201720182019202020212022202320242025
XVIPY Cash Flows (SEK) by year
PeriodCash Flows (SEK)
2025-60.75M
202451.36M
20233.27M
20229.67M
2021-22.25M
2020-15M
201919.13M
201826.02M
201716.47M
20163.94M
EPS (SEK)
-0.500.511.52016201720182019202020212022202320242025
XVIPY EPS (SEK) by year
PeriodEPS (SEK)
20250.2
20241.37
20230.74
20220.16
20210.04
2020-0.39
20190.04
20180.12
20170.06
20160.02
Expenses (SEK)
0200M400M600M800MR&DSG&ACapex2016201720182019202020212022202320242025
XVIPY Expenses (SEK) by year
PeriodExpenses (SEK)
2025627.14M
2024590.2M
2023469.87M
2022310.9M
2021217.61M
2020149.15M
2019158.68M
2018125.16M
2017108.94M
2016105.48M
Cash & Debt (SEK)
-200M0200M400M600MCashLong Term DebtShort Term Debt2016201720182019202020212022202320242025
XVIPY Cash & Debt (SEK) by year
PeriodCash & Debt (SEK)
2025292.1M
2024415.52M
2023546.09M
2022246.54M
2021398.7M
2020353.44M
2019159.15M
2018186.26M
2017195.02M
201623.37M
Debt ratios
-15-10-5020182019202020212022202320242025
XVIPY Debt ratios by year
PeriodDebt ratios
2025-0.34
2024-1.01
2023-2.47
2022-3.01
2021-9.89
2020-10.88
2019-1.92
2018-2.97
Margins
0%20%40%60%80%2016201720182019202020212022202320242025
XVIPY Margins by year
PeriodMargins
202569.64%
202474.95%
202369.59%
202271.51%
202172.87%
202073.93%
201973.73%
201872.37%
201776.44%
201673.99%
Return on Capital
-5%0%5%10%2016201720182019202020212022202320242025
XVIPY Return on Capital by year
PeriodReturn on Capital
20251.16%
20247.98%
20234.72%
20221.29%
20210.63%
2020-4.34%
20190.86%
20182.35%
20171.24%
20160.47%
Shares Outstanding
050M100M150M2016201720182019202020212022202320242025
XVIPY Shares Outstanding by year
PeriodShares Outstanding
2025126M
2024126.25M
2023126M
2022118.41M
2021125.71M
2020114.41M
2019106.4M
2018105.61M
2017104.76M
201692.46M
Book Value Per Share (SEK)
051015202016201720182019202020212022202320242025
XVIPY Book Value Per Share (SEK) by year
PeriodBook Value Per Share (SEK)
202516.77
202417.08
202315.44
202212.08
202110.23
20208.81
20195.43
20185.12
20174.81
20163.42
Total Assets (SEK)
01B2B3B2016201720182019202020212022202320242025
XVIPY Total Assets (SEK) by year
PeriodTotal Assets (SEK)
20252.37B
20242.4B
20232.2B
20221.73B
20211.54B
20201.15B
2019634.49M
2018586.61M
2017538.54M
2016349.3M
PE Ratio
0200400600800med 133.13Mar 23Jul 24Sep 24Nov 24Sep 25Dec 25Sep 26
XVIPY PE Ratio by year
PeriodPE Ratio
Sep 26111.95
Aug 26120.22
Aug 26131.52
Jun 26347.5
Feb 26239.99
Jan 26242.89
Dec 2548.65
Dec 2549.91
Nov 2549.63
Nov 2545.81
Nov 2550.85
Oct 2555.71
Sep 2540.08
Jul 2550.04
Jun 2565.08
Jun 2553.48
Jun 2553.71
Nov 24121.12
Nov 24120.03
Oct 24127.26
Oct 24134.73
Oct 24128.5
Oct 24130.47
Sep 24161.1
Sep 24158.2
Sep 24159.02
Aug 24166.01
Aug 24169.57
Aug 24159.99
Aug 24151.79
Jul 24170.14
May 24149.68
Apr 24109.42
Aug 23295.41
May 23471.92
Apr 23392.62
Mar 23244.77
Dec 22240.64
Nov 22222.6
Sep 22773.69
Free Cash Flow Yield
-1%-0.5%0%0.5%1%med 0.04%Mar 23Jul 24Sep 24Nov 24Sep 25Dec 25Sep 26
XVIPY Free Cash Flow Yield by year
PeriodFree Cash Flow Yield
Sep 26-0.33%
Aug 26-0.3%
Aug 26-0.28%
Jun 26-0.71%
Feb 26-0.29%
Jan 26-0.29%
Dec 250.04%
Dec 250.04%
Nov 250.04%
Nov 250.04%
Nov 250.03%
Oct 250.03%
Sep 250.62%
Jul 250.5%
Jun 250.38%
Jun 250.56%
Jun 250.56%
Nov 240.04%
Nov 240.04%
Oct 240.04%
Oct 240.04%
Oct 240.04%
Oct 240.04%
Sep 240.06%
Sep 240.06%
Sep 240.06%
Aug 240.06%
Aug 240.06%
Aug 240.06%
Aug 240.06%
Jul 240.06%
May 240.02%
Apr 240.03%
Aug 230%
May 230.11%
Apr 230.13%
Mar 23-0.16%
Dec 22-0.59%
Nov 22-0.63%
Sep 22-0.81%
Price to Sales
0102030med 17.28Mar 23Jul 24Sep 24Nov 24Sep 25Dec 25Sep 26
XVIPY Price to Sales by year
PeriodPrice to Sales
Sep 269.97
Aug 2610.71
Aug 2611.72
Jun 2610.56
Feb 268.83
Jan 268.94
Dec 256.58
Dec 256.76
Nov 256.72
Nov 256.2
Nov 256.88
Oct 257.54
Sep 256.42
Jul 258.02
Jun 2510.43
Jun 2511.2
Jun 2511.24
Nov 2420.93
Nov 2420.74
Oct 2421.99
Oct 2423.28
Oct 2422.2
Oct 2422.54
Sep 2425.16
Sep 2424.71
Sep 2424.84
Aug 2425.93
Aug 2426.49
Aug 2424.99
Aug 2423.71
Jul 2426.58
May 2423
Apr 2416.81
Aug 2317.75
May 2320.94
Apr 2317.42
Mar 2319.79
Dec 2217.15
Nov 2215.86
Sep 2218.2
EV/EBITDA
255075100125150med 75.05Mar 23Jul 24Sep 24Nov 24Sep 25Dec 25Sep 26
XVIPY EV/EBITDA by year
PeriodEV/EBITDA
Sep 2651.15
Aug 2655.02
Aug 2660.3
Jun 2657.51
Feb 2659.49
Jan 2660.23
Dec 2550.05
Dec 2551.4
Nov 2551.1
Nov 2547.01
Nov 2552.4
Oct 2557.61
Sep 2539.53
Jul 2549.9
Jun 2565.55
Jun 2568.04
Jun 2568.34
Nov 2473.14
Nov 2472.46
Oct 2476.96
Oct 2481.62
Oct 2477.73
Oct 2478.96
Sep 2493.83
Sep 2492.08
Sep 2492.58
Aug 2496.77
Aug 2498.91
Aug 2493.16
Aug 2488.24
Jul 2499.25
May 2485.34
Apr 2461.49
Aug 23112.36
May 23129.97
Apr 23107.52
Mar 23131.09
Dec 22102.65
Nov 2294.51
Sep 22139.5
Price/Operating Cashflow
050010001500med 211.03Mar 23Jul 24Sep 24Nov 24Sep 25Dec 25Sep 26
XVIPY Price/Operating Cashflow by year
PeriodPrice/Operating Cashflow
Sep 2646.86
Aug 2650.33
Aug 2655.06
Jun 2689.53
Feb 2695.43
Jan 2696.58
Dec 2569.01
Dec 2570.81
Nov 2570.41
Nov 2564.99
Nov 2572.14
Oct 2579.03
Sep 2558.14
Jul 2572.59
Jun 2594.41
Jun 2582.74
Jun 2583.09
Nov 24211.03
Nov 24209.13
Oct 24221.73
Oct 24234.74
Oct 24223.88
Oct 24227.31
Sep 24268.29
Sep 24263.46
Sep 24264.83
Aug 24276.46
Aug 24282.39
Aug 24266.45
Aug 24252.79
Jul 24283.34
May 24296.92
Apr 24217.07
Aug 23331.92
May 23312.18
Apr 23259.72
Mar 231328.65
Price to Book
246810med 4.8Mar 23Jul 24Sep 24Nov 24Sep 25Dec 25Sep 26
XVIPY Price to Book by year
PeriodPrice to Book
Sep 263.87
Aug 264.15
Aug 264.54
Jun 264.02
Feb 263.43
Jan 263.47
Dec 252.59
Dec 252.66
Nov 252.64
Nov 252.44
Nov 252.71
Oct 252.97
Sep 252.62
Jul 253.28
Jun 254.26
Jun 254.27
Jun 254.29
Nov 247.22
Nov 247.16
Oct 247.59
Oct 248.03
Oct 247.66
Oct 247.78
Sep 248.08
Sep 247.93
Sep 247.97
Aug 248.32
Aug 248.5
Aug 248.02
Aug 247.61
Jul 248.53
May 247.07
Apr 245.17
Aug 235.68
May 236.08
Apr 235.06
Mar 235.29
Dec 224.18
Nov 223.86
Sep 224.1
Xvivo Perfusion AB (publ)
XVIPY
Stockpicker

Video analysis: XVIPY

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: XVIPY

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.